The stock of Intelligent Bio Solutions Inc (INBS) has gone down by -22.82% for the week, with a -48.20% drop in the past month and a -21.23% drop in the past quarter. The volatility ratio for the week is 11.88%, and the volatility levels for the past 30 days are 10.95% for INBS. The simple moving average for the past 20 days is -34.97% for INBS’s stock, with a -30.01% simple moving average for the past 200 days.
Is It Worth Investing in Intelligent Bio Solutions Inc (NASDAQ: INBS) Right Now?
The stock has a 36-month beta value of 4.23. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for INBS is 6.66M, and at present, short sellers hold a 6.79% of that float. On April 09, 2025, the average trading volume of INBS was 212.31K shares.
INBS) stock’s latest price update
Intelligent Bio Solutions Inc (NASDAQ: INBS)’s stock price has dropped by -12.88 in relation to previous closing price of 1.32. Nevertheless, the company has seen a loss of -22.82% in its stock price over the last five trading days. globenewswire.com reported 2025-03-31 that NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has integrated Arabic as the second international language to its Intelligent Fingerprinting Drug Screening System as part of the Company’s multilingual upgrade. The addition of Arabic follows INBS’s previously announced expansion plans in the Middle East in early 2025, through its partnership with Ivy Diagnostics.
INBS Trading at -41.26% from the 50-Day Moving Average
After a stumble in the market that brought INBS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -70.66% of loss for the given period.
Volatility was left at 10.95%, however, over the last 30 days, the volatility rate increased by 11.88%, as shares sank -47.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.44% lower at present.
During the last 5 trading sessions, INBS fell by -22.82%, which changed the moving average for the period of 200-days by -38.34% in comparison to the 20-day moving average, which settled at $1.7685. In addition, Intelligent Bio Solutions Inc saw -17.86% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for INBS
Current profitability levels for the company are sitting at:
- -4.33 for the present operating margin
- 0.1 for the gross margin
The net margin for Intelligent Bio Solutions Inc stands at -5.13. The total capital return value is set at -2.01. Equity return is now at value -279.80, with -122.18 for asset returns.
Based on Intelligent Bio Solutions Inc (INBS), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -5.52. The debt to equity ratio resting at 0.33. The interest coverage ratio of the stock is 55.65.
Currently, EBITDA for the company is -8.81 million with net debt to EBITDA at 0.0. When we switch over and look at the enterprise to sales, we see a ratio of 0.23. The receivables turnover for the company is 6.44for trailing twelve months and the total asset turnover is 0.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.89.
Conclusion
To sum up, Intelligent Bio Solutions Inc (INBS) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
